4 References 1. Paul AK, Smith CG, Rahmattullah M, Nissapatorn V, Wilairatana P, Spetea M, Gueven N, Diteis N. Opioid analgesia and opioid-induced adverse effects: a review. Pharmaceut (Basel). 2021; 14: 1091 doi: 10.3390/ph14111091. 2. Shafi S, Collinsworth AW, Copeland LA, Ogola GO, Qiu T, Kouznetsova M, Liao IC, Mears N, Pham AT, Wan GJ, Masica AL. Association of OpioidRelated Adverse Drug Events With Clinical and Cost Outcomes Among Surgical Patients in a Large Integrated Health Care Delivery System. Jama Surgery. 2018; 153: 757–763 doi: 10.1001/jamasurg.2018.1039. 3. Kessler ER, Shah M, Gruschkus SK, Raju A. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacother. 2013; 33: 383–91 doi: 10.1002/phar.2013.33.issue-4. 4. Boom M, Niesters M, Sarton E, Aarts L, Smith TW, Dahan A. Nonanalgesic effects of opioids: opioid-induced respiratory depression. Curr PharmDes. 2012; 18: 5994–6004 doi: 10.2174/138161212803582469. 5. Mann J, Samieegohar M, Chaturbedi A, Zikle J, Han X, Ahmadi SF, Eshleman A, Janowsky A, Wolfrum K, Swanson T, Bloom S, Dahan A, Olofsen E, Florian J, Strauss D, Li Z. Development of a translational model to assess the impact of opioid overdose and naloxone dosing on respiratory depression and cardiac arrest. Clin Pharmacol Ther. 2022; doi: 10.1002/cpt.v112.5. 6. Kharasch ED, Avram MJ, Clark JD. Rational perioperative opioid management in the era of the opioid epidemic. Anesthesiology. 2020; 132: 603–5 doi: 10.1097/ALN.0000000000003166. 93
RkJQdWJsaXNoZXIy MTk4NDMw